Cholestyramine
NDC 33342-319, Cholestyramine, powder, for suspension, from Macleods Pharmaceuticals Limited.
- Product NDC
- 33342-319
- Status
- Listed
- Labeler
- Macleods Pharmaceuticals Limited
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA209109
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/33342-319 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CHOLESTYRAMINE4 g/5.7g
Pharmacologic classes
Bile Acid Sequestrant [EPC]; Bile-acid Binding Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 33342-319-70 | 33342031970 | 60 POUCH in 1 CARTON (33342-319-70) / 5.7 g in 1 POUCH (33342-319-01) |
| 33342-319-72 | 33342031972 | 42 POUCH in 1 CARTON (33342-319-72) / 5.7 g in 1 POUCH (33342-319-01) |
| 33342-319-83 | 33342031983 | 239.4 g in 1 JAR (33342-319-83) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/c41529f1-16d2-4ca3-91eb-f809571f5ae3
Use it
Look up 33342-319 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/33342-319 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 33342-319. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.